Ideate Ipilimumab Drug Evaluation Immunotherapy In Squamous NSCLC Trademark Details

Ideate Ipilimumab Drug Evaluation Immunotherapy in Squamous Nsclc was registered on Tuesday, February 18, 2014 and is currently owned by Bristol-Myers Squibb Company under the registration number 4485747 . This mark is alive with a status of Registered. The last case file activity for this mark occured 10 years ago on Tuesday, February 18, 2014, according to the United State Patent & Trademark Office
Word Mark Ideate Ipilimumab Drug Evaluation Immunotherapy in Squamous Nsclc
Status Alive Registered 700 — Registered

Current Owner

Bristol-Myers Squibb Company of New York, NY

View all trademarks for Bristol-Myers Squibb Company
Other Trademarks for Bristol-Myers Squibb Company
Serial Number 85595704
Registration Number 4485747
Status Date Tuesday, February 18, 2014
Filing Date Tuesday, February 18, 2014
Registration Date Tuesday, February 18, 2014
Attorney Marilyn F. Kelly

Correspondent

Marilyn F. Kelly
BRISTOL-MYERS SQUIBB COMPANY
TRADEMARKS DEPT. - MAILSTOP D33-05
P.O. BOX 4000
PRINCETON NJ 08648-4000

Case File Statements

Indication of Colors Color is not claimed as a feature of the mark.
Disclaimer with Predetermined Text "Ipilimumab Drug Evaluation" and "Immunotherapy in Squamous Nsclc"
Description of Mark The mark consists of the words "IDEATE IPILIMUMAB DRUG EVALUATION" in stylized letters above an oblong containing the words "IMMUNOTHERAPY IN SQUAMOUS NSCLC", all against stylized chromosomes and a stylized DNA strand.
Goods & Services Product research and development; conducting clinical trials relating to pharmaceutical preparations for human use

Classifications

International Class Codes
042 — Class 42 includes mainly services provided by persons, individually or collectively, in relation to the theoretical and practical aspects of complex fields of activities; such services are provided by members of professions such as chemists, physicists, engineers, computer programmers, etc.
U.S. Class Codes 100, 101
Status 6 — Active
Status Date Thursday, April 19, 2012
First Use Anywhere Friday, May 31, 2013
First Use In Commerce Friday, May 31, 2013
Primary Code 042

You must be signed in to print.

Once signed in, look for the PDF button.